We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3301
Vanda Pharmaceuticals
VNDA
$256M
| $411 | ﹤0.01% |
87
| – | – |
2024 Q1
5 quarters
|
|
3302
VanEck Fabless Semiconductor ETF
SMHX
$258M
| $407 | ﹤0.01% |
+13
| New | +$339 |
2025 Q2
0 quarters
|
|
3303
NerdWallet
NRDS
$641M
| $406 | ﹤0.01% |
37
-23
| -38% | -$231 |
2024 Q4
2 quarters
|
|
3304
X Financial
XYF
$189M
| $402 | ﹤0.01% |
23
-14
| -38% | -$215 |
2025 Q1
1 quarter
|
|
3305
Protolabs
PRLB
$2.09B
| $400 | ﹤0.01% |
10
| – | – |
2019 Q3
23 quarters
|
|
3306
Agios Pharmaceuticals
AGIO
$1.93B
| $399 | ﹤0.01% |
12
-492
| -98% | -$14.9K |
2024 Q2
4 quarters
|
|
3307
DELISTED
ESS Tech
GWH
| $399 | ﹤0.01% |
300
-5,518
| -95% | -$10.3K |
2025 Q1
1 quarter
|
|
3308
IMAX
IMAX
$2.83B
| $391 | ﹤0.01% |
14
-1
| -7% | -$26 |
2025 Q1
1 quarter
|
|
3309
DELISTED
Olympic Steel
ZEUS
| $391 | ﹤0.01% |
+12
| New | +$374 |
2025 Q2
0 quarters
|
|
3310
Ouster
OUST
$2.26B
| $388 | ﹤0.01% |
16
-122
| -88% | -$1.48K |
2024 Q4
2 quarters
|
|
3311
Destiny Tech100
DXYZ
$884M
| $381 | ﹤0.01% |
+10
| New | +$379 |
2025 Q2
0 quarters
|
|
3312
Bankunited
BKU
$2.99B
| $375 | ﹤0.01% |
11
-19
| -63% | -$638 |
2016 Q4
34 quarters
|
|
3313
LendingTree
TREE
$363M
| $371 | ﹤0.01% |
10
| – | – |
2020 Q1
21 quarters
|
|
3314
Carriage Services
CSV
$574M
| $366 | ﹤0.01% |
8
| – | – |
2023 Q4
6 quarters
|
|
3315
SES AI
SES
$328M
| $364 | ﹤0.01% |
+410
| New | +$344 |
2025 Q2
0 quarters
|
|
3316
MannKind Corp
MNKD
$1.03B
| $363 | ﹤0.01% |
97
-1,394
| -93% | -$6.14K |
2022 Q2
12 quarters
|
|
3317
Aviat Networks
AVNW
$250M
| $361 | ﹤0.01% |
15
| – | – |
2023 Q4
6 quarters
|
|
3318
Biomea Fusion
BMEA
$60.6M
| $360 | ﹤0.01% |
+200
| New | +$385 |
2025 Q2
0 quarters
|
|
3319
Paymentus
PAY
$4.05B
| $360 | ﹤0.01% |
11
+2
| +22% | +$67 |
2025 Q1
1 quarter
|
|
3320
Greenlight Captial
GLRE
$481M
| $359 | ﹤0.01% |
+25
| New | +$344 |
2025 Q2
0 quarters
|
|
3321
Invivyd
IVVD
$197M
| $355 | ﹤0.01% |
496
| – | – |
2024 Q3
3 quarters
|
|
3322
Oil-Dri
ODC
$1.17B
| $354 | ﹤0.01% |
+6
| New | +$291 |
2025 Q2
0 quarters
|
|
3323
AdvisorShares Focused Equity ETF
CWS
$121M
| $350 | ﹤0.01% |
5
| – | – |
2024 Q3
3 quarters
|
|
3324
Portillo's
PTLO
$347M
| $350 | ﹤0.01% |
+30
| New | +$346 |
2025 Q2
0 quarters
|
|
3325
DELISTED
E2open Parent Holdings
ETWO
| $349 | ﹤0.01% |
108
-206
| -66% | -$542 |
2023 Q2
8 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.